As a leading innovation in glaucoma treatment, developed by New World Medical, the Ahmed ClearPath is a clear choice for ophthalmologists seeking effective, non-valved implant solutions for intraocular pressure (IOP) management. With its thoughtful design and convenient features, the device supports both efficient surgical implantation and long-term patient outcomes (1).
Innovative design for reliable IOP control
The Ahmed Clear Path introduces an innovative solution for non-valved glaucoma drainage devices, providing surgeons with precise control over IOP management. Its flexible plate material and low-lying profile are designed to promote the formation of a low diffuse bleb, enhancing IOP stability over the long term (2).
Single-quadrant implantation for surgical convenience
Designed with convenience in mind, the Ahmed ClearPath is available in two sizes: 250 mm2 and 350 mm2. The 250mm2 model facilitates a true single-quadrant implantation between the rectus muscles, eliminating the need for muscle isolation, streamlining the procedure and simplifying positioning. Meanwhile the 350mm2 model features a winged design that stabilizes beneath the rectus muscles without direct attachment, further supporting stable positioning. This range of options provides surgeons with the flexibility to select the best fit for each patient’s needs and reduce the surgical complexity associated with overall implant placement.
References
- WS Shalaby et al., “Ahmed ClearPath vs. Baerveldt Glaucoma Implant: A Retrospective Noninferiority Comparative Study,” Ophthalmol Glaucoma, 7, 251 (2024). PMID: 38158079.
- RC Barão et al., “Bleb morphology of glaucoma drainage devices on magnetic resonance imaging,” Acta Ophthalmol, 101, 789 (2023). PMID: 37066864.